# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4067020 | 18 | IP | = | 46 | nM | ALA4012173 | nM | ||||
2. | ALA4067020 | 18 | Ratio | = | 3 | ALA4012178 | ||||||
3. | ALA4067020 | 18 | Ratio | = | 1 | ALA4012177 | ||||||
4. | ALA4067020 | 18 | Ratio | = | 1 | ALA4012176 | ||||||
5. | ALA4067020 | 18 | Ratio | = | 1 | ALA4012175 | ||||||
6. | ALA4067020 | 18 | Ratio | = | 2 | ALA4012174 | ||||||
7. | ALA4067020 | 18 | Ratio | = | 1 | ALA4012162 | ||||||
8. | ALA4067020 | 18 | IP | = | 23 | nM | ALA4012172 | nM | Human immunodeficiency virus 1 | |||
9. | ALA4067020 | 18 | IP | = | 8 | nM | ALA4012171 | nM | Human immunodeficiency virus 1 | |||
10. | ALA4067020 | 18 | IP | = | 7 | nM | ALA4012170 | nM | Human immunodeficiency virus 1 | |||
11. | ALA4067020 | 18 | IP | = | 7 | nM | ALA4012169 | nM | Human immunodeficiency virus 1 | |||
12. | ALA4067020 | 18 | IP | = | 11 | nM | ALA4012168 | nM | Human immunodeficiency virus 1 | |||
13. | ALA4067020 | 18 | IP | = | 7 | nM | ALA4012167 | nM | Human immunodeficiency virus 1 | |||
14. | ALA4067020 | 18 | IP | = | 7 | nM | ALA4012166 | nM | ||||
15. | ALA4067020 | 18 | F | <= | 4.5 | % | ALA4012164 | % | Canis lupus familiaris | |||
16. | ALA4067020 | 18 | t1/2 | = | 6.6 | hr | ALA4012163 | hr | Canis lupus familiaris | |||
17. | ALA4067020 | 18 | Vd | = | 2.1 | l | ALA4012161 | l | Canis lupus familiaris | |||
18. | ALA4067020 | 18 | CL | = | 7.3 | ml/min.kg | ALA4012160 | mL.min-1.kg-1 | Canis lupus familiaris | |||
19. | ALA4067020 | 18 | solubility | = | 48 | uM | ALA4012159 | nM | ||||
20. | ALA4067020 | 18 | solubility | = | 89 | uM | ALA4012158 | nM |